NCT00970580: A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer |
|
|
| Completed | 1b | 18 | US | BIIB022 With Paclitaxel and Carboplatin, Taxol, Paraplatin, BIIB022, Taxane, Anti-IGF-1R, Cytotoxic, Mitotic Inhibitor, IGF-1R, Alkylating agent | Biogen | Non-Small Cell Lung Cancer | 09/11 | 09/11 | | |
